Logo image of DHAC

DIGITAL HEALTH ACQUISTION CO (DHAC) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:DHAC - US2538931013 - Common Stock

12.1099 USD
+0.54 (+4.69%)
Last: 6/24/2024, 8:00:01 PM
12.49 USD
+0.38 (+3.14%)
After Hours: 6/24/2024, 8:00:01 PM
Fundamental Rating

0

Overall DHAC gets a fundamental rating of 0 out of 10. We evaluated DHAC against 0 industry peers in the Unkown industry. DHAC may be in some trouble as it scores bad on both profitability and health. DHAC is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

DHAC had negative earnings in the past year.
DHAC had a negative operating cash flow in the past year.
DHAC Yearly Net Income VS EBIT VS OCF VS FCFDHAC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 -1M -2M -3M -4M

1.2 Ratios

Industry RankSector Rank
ROA -251.63%
ROE N/A
ROIC N/A
ROA(3y)-121.64%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DHAC Yearly ROA, ROE, ROICDHAC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 -100 -200 -300

1.3 Margins

DHAC does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
DHAC Yearly Profit, Operating, Gross MarginsDHAC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023

More info and screens

0

2. Health

2.1 Basic Checks

DHAC has less shares outstanding than it did 1 year ago.
Compared to 1 year ago, DHAC has a worse debt to assets ratio.
DHAC Yearly Shares OutstandingDHAC Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 5M 10M
DHAC Yearly Total Debt VS Total AssetsDHAC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

DHAC has an Altman-Z score of -25.79. This is a bad value and indicates that DHAC is not financially healthy and even has some risk of bankruptcy.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -25.79
ROIC/WACCN/A
WACCN/A
DHAC Yearly LT Debt VS Equity VS FCFDHAC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 20M 40M 60M 80M 100M

2.3 Liquidity

A Current Ratio of 0.00 indicates that DHAC may have some problems paying its short term obligations.
A Quick Ratio of 0.00 indicates that DHAC may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0
Quick Ratio 0
DHAC Yearly Current Assets VS Current LiabilitesDHAC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2M 4M 6M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for DHAC have decreased strongly by -25.99% in the last year.
EPS 1Y (TTM)-25.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40.32%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for DHAC. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DHAC Price Earnings VS Forward Price EarningsDHAC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DHAC Per share dataDHAC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -1 -2 -3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for DHAC!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DIGITAL HEALTH ACQUISTION CO

NASDAQ:DHAC (6/24/2024, 8:00:01 PM)

After market: 12.49 +0.38 (+3.14%)

12.1099

+0.54 (+4.69%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)05-15 2024-05-15
Earnings (Next)08-19 2024-08-19
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners7.9%
Ins Owner Change0%
Market Cap43.60M
Revenue(TTM)N/A
Net Income(TTM)-3.49M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.93
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.27
FCFYN/A
OCF(TTM)-0.27
OCFYN/A
SpS0
BVpS-3.32
TBVpS-3.32
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -251.63%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-121.64%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0
Quick Ratio 0
Altman-Z -25.79
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-25.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40.32%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y31.97%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y30.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y30.79%
OCF growth 3YN/A
OCF growth 5YN/A

DIGITAL HEALTH ACQUISTION CO / DHAC FAQ

What is the ChartMill fundamental rating of DIGITAL HEALTH ACQUISTION CO (DHAC) stock?

ChartMill assigns a fundamental rating of 0 / 10 to DHAC.


What is the valuation status for DHAC stock?

ChartMill assigns a valuation rating of 0 / 10 to DIGITAL HEALTH ACQUISTION CO (DHAC). This can be considered as Overvalued.


What is the profitability of DHAC stock?

DIGITAL HEALTH ACQUISTION CO (DHAC) has a profitability rating of 0 / 10.